Name:
Bacillus subtilis (Ehrenberg 1835) Cohn 1872
DSM No.:
28592 dsm-28592 dsm28592 dsm 28592 Bacillus subtilis
Strain designation:
Amp-T18
Isolated from:
caecal content; wildtype C57BL/6 mouse treated with ampicillin
Date of sampling:
Aug-2010
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- T. Clavel, TU Munich, Freising-Weihenstephan, Germany; Amp-T18
Genbank accession numbers:
Summary and
additional information:
<- T. Clavel, TU Munich, Freising-Weihenstephan, Germany; Amp-T18. Caecal content; wildtype C57BL/6 mouse treated with ampicillin; Germany, Freising. Taxonomy/description (25850). Sequence accession no. 16S rRNA gene: KR364738. (Medium 381, 37°C).
Risk group:
1 (+) (classification according to German
TRBA)
Restrictions:
Commercial use is completely excluded for this strain. For a request for commercial use please contact the depositor: tclavel@ukaachen.de
Supplied as:
| Delivery form | | Prices |
|
| Freeze Dried | | 100,- € |
| Active culture on request | | 240,- € |
| DNA | | 150,- € | |
| Price Category for this culture: 1 |
Freight and handling charges will be added.
See price list.
